Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB108 Latest Draft

Bill / Engrossed Version Filed 04/27/2023

                             
 
ENGR. H. A. to ENGR. S. B. NO. 108 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED HOUSE AMENDME NT 
 TO 
ENGROSSED SENATE BILL NO . 108 By: Bergstrom and Standridge of 
the Senate 
 
  and 
 
  Ford of the House 
 
 
 
 
An Act relating to the Uniform Controlled Dangerous 
Substances Act; amending 63 O.S. 2021, Section 2 -402, 
as amended by Section 3, State Quest ion No. 780, 
Initiative Petition No. 404, which relates to 
prohibited acts and pen alties; updating statutory 
reference; providing for misdemeanor upon conviction; 
authorizing the court to make certain orders under 
certain circumstances; authorizing certain drug 
testing requirement; authorizing the court to impose 
certain punishment; requiring certain felony; 
requiring certain felony change to a misdemeanor 
under certain circumstances; prohibiting application 
of certain provisions for possession of marijuan a; 
and providing an effective date. 
 
 
 
 
AMENDMENT NO. 1.  Page 1, Lines 6 through 1 2 1/2, strike the title 
to read as follows: 
 
 
"[ Uniform Controlled Dangerous Substances Act – 
prohibited acts and penalties – misdemeanor – 
misdemeanor upon conviction – court orders – felony 
– felony change to a misdemeanor – effective date 
]"   
 
ENGR. H. A. to ENGR. S. B. NO. 108 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Passed the House of Representatives the 26th day of April, 2023. 
 
 
 
 
  
Presiding Officer of the House of 
 	Representatives 
 
 
Passed the Senate the ____ day of __________, 2023. 
 
 
 
 
  
Presiding Officer of the Senate 
   
 
ENGR. S. B. NO. 108 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED SENATE 
BILL NO. 108 	By: Bergstrom and Standridge of 
the Senate 
 
  and 
 
  Ford of the House 
 
 
 
An Act relating to the Uniform Controlled Dangerous 
Substances Act; amending 63 O.S. 2021, Secti on 2-402, 
as amended by Section 3, State Quest ion No. 780, 
Initiative Petition No. 404, which relates to 
prohibited acts and pen alties; updating statutory 
reference; providing for misdemeanor upon conviction; 
authorizing the court to make certain orders un der 
certain circumstances; authorizing certain drug 
testing requirement; authorizing the court to impose 
certain punishment; requiring certain felony; 
requiring certain felony change to a misdemeanor 
under certain circumstances; prohibiting application 
of certain provisions for possession of marijuan a; 
and providing an effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 2 -402, as 
amended by Section 3, State Question No. 780, Initiative Petition 
No. 404, is amended to read as follows: 
Section 2-402.  A.  1.  It shall be unlawful for any person 
knowingly or intentionally to possess a controlled dangerous 
substance unless such substance was obtained d irectly, or pursuant 
to a valid prescription or order from a practitioner, while acting 
in the course of his or her prof essional practice, or except as   
 
ENGR. S. B. NO. 108 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
otherwise authorized by this act Section 2-101 et seq. of this 
title. 
2.  It shall be unlawful for any p erson to purchase an y 
preparation excepted from the provi sions of the Uniform Controlled 
Dangerous Substances Act pursua nt to Section 2-313 of this title in 
an amount or within a time interval other than that permitt ed by 
Section 2-313 of this title. 
3.  It shall be unlawful for any person or business to sell, 
market, advertise or label any product containing ephedrine, its 
salts, optical isomers, or salts of optical isomers, for the 
indication of stimulation, mental alertness, weight loss, appetite 
control, muscle development , energy or other indication which is not 
approved by the pertinent federal OTC Final Monograph, Ten tative 
Final Monograph, or FDA -approved new drug application or its legal 
equivalent.  In determ ining compliance with this requirement, the 
following factors shall be considered: 
a. the packaging of the product, 
b. the name of the product, and 
c. the distribution and promotion of the product, 
including verbal representations made at the point of 
sale. 
B. 1. Any person who violates this s ection is guilty of a 
misdemeanor punishable by confineme nt for not more than one (1) year 
and by a fine not exceeding O ne Thousand Dollars ($1,000.00) .   
 
ENGR. S. B. NO. 108 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  Any person who violates this section a second time within 
ten (10) years, upon conviction, shall be guilty of a misdemeanor.  
The court may, with the consen t of the defendant, order the 
defendant to complete a substa nce abuse assessment and evaluation 
and to complete a diversion program for up to one (1) year following 
the date of conviction in lieu of other punishments.  At the 
discretion of the court, the diversion program may include drug 
testing as a requirement.  If the defendant refuses or fails to 
complete the assessment and evaluation or diversion program , the 
court may impose punishment as provided for in paragraph 1 of this 
subsection. 
3.  Any person who violates this section a third time within ten 
(10) years shall, upon conviction, be guilty of a misdemeanor 
punishable by a fine not exceeding One Thousand Dollars ($1,000.00) , 
imprisonment in the county jail for a minimum of thirty (30) days , 
or by both such fine and imprisonment.  The court may, with the 
consent of the defendant, order the defendant to complete a 
substance abuse assessment and evaluation and to complete a 
diversion program for up to three (3) years following the date of 
conviction.  At the discretion of the court, the diversion program 
may include drug testing as a requirement .  If the defendant refuses 
or fails to complete the assessment and evaluation or d iversion 
program, the court may impose punishment as provided for in 
paragraph 1 of this subsection.   
 
ENGR. S. B. NO. 108 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
4. a. Any person who violates this section a fourth time 
within ten (10) year s shall, upon conviction, be 
guilty of a felony punishable by a fine not exceeding 
Five Thousand Dollars ($5,000.00), imprisonment in the 
custody of the Department of Corrections for not less 
than one (1) year nor mo re than five (5) years , or by 
both such fine and imprisonment . 
b. Upon a verdict or plea of guilty or upon a plea of 
nolo contendere, but before a judgment of guilt of a 
violation of this paragr aph, the court may, without 
entering a judgment of guilt and with the consent of 
the defendant, defer further proceedings upon the 
specific conditions prescribed by the court not to 
exceed a three-year period.  The court may, with the 
consent of the defend ant, order the defendant to 
complete a substance abuse asse ssment and evaluation 
and to complete a diversi on program for up to three 
(3) years. 
c. Upon successful completion of the court-ordered 
substance abuse assessment and evaluation and 
diversion program ordered by the court within the time 
prescribed, the felony charge shall be changed to a 
misdemeanor.  If the defendant refuses or fails to 
complete the assessment and evaluation or diversion   
 
ENGR. S. B. NO. 108 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
program, the court may impose punishment as provided 
for in subparagraph a of this paragraph. 
5.  The provisions of this subsection shall not apply f or 
violations related to the possession of marijuana . 
C. Any person convicted of any offense described in thi s 
section shall, in addition to any fine imposed, pay a special 
assessment trauma-care fee of One Hundred Dolla rs ($100.00) to be 
deposited into the Trauma Care Assistance Revolving Fund created in 
Section 1-2530.9 of this title. 
SECTION 2.  This act shall become effective November 1, 2023. 
Passed the Senate the 22nd day of March, 2023. 
 
 
  
 	Presiding Officer of the Senate 
 
 
Passed the House of Representatives the ____ day of __________, 
2023. 
 
 
  
 	Presiding Officer of the House 
 	of Representatives